MIP
PFE icon

Mondrian Investment Partners’s Pfizer PFE Stock Holding History

Mondrian Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,360
Closed -$122K – 118
2026
Q1 		$122K Buy
+4,360
New +$116K ﹤0.01% 86
2019
Q1 		– Sell
-626,729
Closed -$26M – 128
2018
Q4 		$26M Sell
626,729
-770,996
-55% -$32M 0.95% 37
2018
Q3 		$58.4M Sell
1,397,725
-1,158,760
-45% -$44.6M 1.83% 21
2018
Q2 		$88M Sell
2,556,485
-7,373
-0.3% -$252K 2.57% 8
2018
Q1 		$89.1M Sell
2,563,858
-353,672
-12% -$12.2M 2.43% 9
2017
Q4 		$100M Sell
2,917,530
-271,042
-9% -$9.24M 2.44% 10
2017
Q3 		$108M Buy
3,188,572
+189,976
+6% +$6.11M 2.74% 10
2017
Q2 		$95.6M Sell
2,998,596
-401,905
-12% -$12.7M 2.73% 9
2017
Q1 		$110M Sell
3,400,501
-298,137
-8% -$9.4M 3.11% 7
2016
Q4 		$114M Buy
3,698,638
+538,420
+17% +$16.4M 3.29% 8
2016
Q3 		$102M Sell
3,160,218
-562,055
-15% -$18.8M 2.48% 12
2016
Q2 		$124M Sell
3,722,273
-115,166
-3% -$3.68M 2.94% 10
2016
Q1 		$108M Buy
3,837,439
+181,813
+5% +$5.19M 2.4% 11
2015
Q4 		$112M Sell
3,655,626
-19,254
-0.5% -$606K 2.46% 11
2015
Q3 		$110M Sell
3,674,880
-300,364
-8% -$9.63M 2.32% 13
2015
Q2 		$126M Sell
3,975,244
-104,007
-3% -$3.39M 2.14% 14
2015
Q1 		$135M Sell
4,079,251
-36,730
-0.9% -$1.17M 2.2% 13
2014
Q4 		$122M Buy
4,115,981
+2,367,674
+135% +$67.9M 1.96% 15
2014
Q3 		$49M Sell
1,748,307
-7,483
-0.4% -$210K 0.68% 36
2014
Q2 		$49.4M Buy
1,755,790
+10,224
+0.6% +$291K 0.69% 39
2014
Q1 		$53.2M Sell
1,745,566
-933,117
-35% -$27.8M 0.78% 38
2013
Q4 		$77.8M Sell
2,678,683
-118,470
-4% -$3.45M 1.09% 26
2013
Q3 		$76.2M Sell
2,797,153
-817,166
-23% -$22.2M 1.12% 24
2013
Q2 		$96M Buy
+3,614,319
New +$99.9M 1.46% 16

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mondrian Investment Partners's PFE Position: Q2 2026 in Review

Mondrian Investment Partners sold out of Pfizer (PFE) in Q2 2026, closing a stake of 4,360 shares — an estimated $122K sold.

Mondrian Investment Partners first reported a position in PFE in Q2 2013 and held it in 24 quarters. The position peaked at $135M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Mondrian Investment Partners reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Mondrian Investment Partners sold 4,360 Pfizer shares in Q2 2026, an estimated $122K.
  • Mondrian Investment Partners first reported a position in Pfizer in Q2 2013 and held it in 24 quarters.
  • Mondrian Investment Partners's Pfizer position peaked at $135M in Q1 2015.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mondrian Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.